138 related articles for article (PubMed ID: 26044768)
1. A 3D-RISM/RISM study of the oseltamivir binding efficiency with the wild-type and resistance-associated mutant forms of the viral influenza B neuraminidase.
Phanich J; Rungrotmongkol T; Sindhikara D; Phongphanphanee S; Yoshida N; Hirata F; Kungwan N; Hannongbua S
Protein Sci; 2016 Jan; 25(1):147-58. PubMed ID: 26044768
[TBL] [Abstract][Full Text] [Related]
2. Role of R292K mutation in influenza H7N9 neuraminidase toward oseltamivir susceptibility: MD and MM/PB(GB)SA study.
Phanich J; Rungrotmongkol T; Kungwan N; Hannongbua S
J Comput Aided Mol Des; 2016 Oct; 30(10):917-926. PubMed ID: 27714494
[TBL] [Abstract][Full Text] [Related]
3. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
Pan P; Li L; Li Y; Li D; Hou T
Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
[TBL] [Abstract][Full Text] [Related]
4. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
Park JW; Jo WH
J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
[TBL] [Abstract][Full Text] [Related]
5. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
Li L; Li Y; Zhang L; Hou T
J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
[TBL] [Abstract][Full Text] [Related]
6. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
Singh A; Soliman ME
Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
[TBL] [Abstract][Full Text] [Related]
7. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
Kar P; Knecht V
J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
[TBL] [Abstract][Full Text] [Related]
8. Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.
Tolentino-Lopez L; Segura-Cabrera A; Reyes-Loyola P; Zimic M; Quiliano M; Briz V; Muñoz-Fernández A; Rodríguez-Pérez M; Ilizaliturri-Flores I; Correa-Basurto J
Biopolymers; 2013 Jan; 99(1):10-21. PubMed ID: 23097226
[TBL] [Abstract][Full Text] [Related]
9. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
[TBL] [Abstract][Full Text] [Related]
10. Analysis and assay of oseltamivir-resistant mutants of influenza neuraminidase via direct observation of drug unbinding and rebinding in simulation.
Woods CJ; Malaisree M; Long B; McIntosh-Smith S; Mulholland AJ
Biochemistry; 2013 Nov; 52(45):8150-64. PubMed ID: 24128064
[TBL] [Abstract][Full Text] [Related]
11. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
Karthick V; Ramanathan K
Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Liu H; Yao X; Wang C; Han J
Mol Pharm; 2010 Jun; 7(3):894-904. PubMed ID: 20420444
[TBL] [Abstract][Full Text] [Related]
13. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.
McKimm-Breschkin JL; Barrett S
Antiviral Res; 2015 Feb; 114():62-6. PubMed ID: 25499124
[TBL] [Abstract][Full Text] [Related]
15. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
[TBL] [Abstract][Full Text] [Related]
16. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
17. Computational Study of Drug Binding Affinity to Influenza A Neuraminidase Using Smooth Reaction Path Generation (SRPG) Method.
Nguyen H; Tran T; Fukunishi Y; Higo J; Nakamura H; Le L
J Chem Inf Model; 2015 Sep; 55(9):1936-43. PubMed ID: 26247106
[TBL] [Abstract][Full Text] [Related]
18. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of drug resistance in A/H1N1 virus.
Vergara-Jaque A; Poblete H; Lee EH; Schulten K; González-Nilo F; Chipot C
J Chem Inf Model; 2012 Oct; 52(10):2650-6. PubMed ID: 22978683
[TBL] [Abstract][Full Text] [Related]
20. Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.
Farrukee R; Leang SK; Butler J; Lee RT; Maurer-Stroh S; Tilmanis D; Sullivan S; Mosse J; Barr IG; Hurt AC
J Antimicrob Chemother; 2015 Jul; 70(7):2004-12. PubMed ID: 25786478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
